Viva Biotech Holdings (VBIZF)
OTCMKTS · Delayed Price · Currency is USD
0.3434
+0.1526 (79.98%)
At close: Jan 26, 2026
Viva Biotech Holdings Market Cap
Viva Biotech Holdings has a market cap or net worth of $637.07 million as of February 12, 2026. Its market cap has increased by 197.36% in one year.
Market Cap
637.07M
Enterprise Value
674.42M
Revenue
256.39M
Ranking
n/a
PE Ratio
26.49
Stock Price
$0.34
Market Cap Chart
Since May 9, 2019, Viva Biotech Holdings's market cap has decreased from 844.70M to 637.07M, a decrease of -24.58%. That is a compound annual growth rate of -4.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 637.07M | 30.54% |
| Dec 31, 2025 | 488.02M | 108.59% |
| Dec 31, 2024 | 233.96M | -18.73% |
| Dec 29, 2023 | 287.88M | -33.04% |
| Dec 30, 2022 | 429.89M | -62.94% |
| Dec 31, 2021 | 1.16B | -48.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 411.40M |
| CytoDyn | 311.51M |
| Silence Therapeutics | 211.61M |
| HST Global | 139.70M |
| Vaxart | 137.92M |
| BioStem Technologies | 92.40M |
| Nuo Therapeutics | 72.43M |
| VitaSpring Biomedical | 51.78M |